Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 7/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.47 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MTHFD1 | P11586 | 1/20 | 0.40 |
| ▸ | MTHFD2 | P13995 | 1/20 | 0.40 |
| ▸ | FPR2 | P25090 | 1/20 | 0.40 |
| ▸ | TYMS | P04818 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21065294 | 1.00 | NAALAD2 (0.47) | NAALAD2FOLH1RIMKLAKDM4EHPGD | |
| SCHEMBL12462479 | 0.91 | JAK2 (0.41) | NAALAD2FOLH1RIMKLAMTHFD1MTHFD2 | |
| SCHEMBL12374474 | 0.90 | ABL1 (0.37) | FOLH1FPR2 | |
| SCHEMBL12462486 | 0.85 | FOLH1 (0.45) | FOLH1 | |
| SCHEMBL12374471 | 0.84 | FOLH1 (0.46) | FOLH1 | |
| SCHEMBL23255654 | 0.79 | ITGB3 (0.45) | KDM4E | |
| SCHEMBL13051269 | 0.78 | GAA (0.38) | KDM4EHPGD | |
| SCHEMBL21065266 | 0.78 | TDP1 (0.43) | KDM4E | |
| SCHEMBL21065264 | 0.78 | TDP1 (0.43) | KDM4E | |
| SCHEMBL21122927 | 0.77 | P2RY12 (0.35) | KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11141368-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | L'OREAL (FR) | 2021-10-12 | — | — | US | disclosed |
| US-11141368-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | L'OREAL (FR) | 2021-10-12 | — | — | US | disclosed |
| US-10813866-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | L'OREAL (FR) | 2020-10-27 | — | — | US | disclosed |
| US-10813866-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | L'OREAL (FR) | 2020-10-27 | — | — | US | disclosed |
| EP-2521530-B1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | OREAL (FR) | 2019-06-26 | — | — | EP | disclosed |
| EP-2521530-B1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | OREAL (FR) | 2019-06-26 | — | — | EP | disclosed |
| US-20180256476-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | L'OREAL (FR) | 2018-09-13 | — | — | US | disclosed |
| US-20130017162-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | L'OREAL (FR) | 2013-01-17 | — | — | US | disclosed |
| US-20130017162-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | L'OREAL (FR) | 2013-01-17 | — | — | US | disclosed |
| US-20130017162-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | L'OREAL (FR) | 2013-01-17 | — | — | US | disclosed |
| WO-2011083243-A1 | COSMETIC TREATMENT METHODS AND KIT | L'OREAL (FR) | 2011-07-14 | — | — | WO | disclosed |
| WO-2011080494-A2 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | L'OREAL (FR) | 2011-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130017162-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | KRT18, KIT, TYR | NAALAD2 3234/4885FOLH1 2171/4885RIMKLA 4154/4885 |
| US-10813866-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | KRT18, KIT, TYR | NAALAD2 3234/4885FOLH1 2171/4885RIMKLA 4154/4885 |
| US-20180256476-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | KRT18, KIT, TYR | NAALAD2 3234/4885FOLH1 2171/4885RIMKLA 4154/4885 |
| US-11141368-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | KRT18, KIT, TYR | NAALAD2 3234/4885FOLH1 2171/4885RIMKLA 4154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.